1. P.026 Erenumab associated with high persistence among Canadian patients for preventive treatment of chronic and episodic migraine in real-world practice. (November 2021) Authors: Bastien, N; Chhibber, S; Gladstone, J; Lanthier-Martel, J; Rochdi, D; Lan, T; Minhas, D; Neish, C Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn's disease patients (EVOLVE) in Canada: Interim results. (16th January 2018) Authors: Bressler, B; Greenup, A -J; Bassel, M; Stein, D; Soni, M; Radulescu, G; Neish, C; Khalid, J M; Demuth, D Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗